EP 1035868 A1 20000920 - USE OF A FIBRINOGEN RECEPTOR-ANTAGONIST FOR PREVENTING DISSEMINATED INTRAVASCULAR COAGULATION
Title (en)
USE OF A FIBRINOGEN RECEPTOR-ANTAGONIST FOR PREVENTING DISSEMINATED INTRAVASCULAR COAGULATION
Title (de)
VERWENDUNG EINES FIBRINOGENREZEPTORANTAGONISTEN ZUR VORBEUGUNG DISSEMINIERTER INTRAVASKULÄRER KOAGULATION
Title (fr)
UTILISATION D'UN ANTAGONISTE DU RECEPTEUR DU FIBRINOGENE POUR LA PREVENTION DE LA COAGULATION INTRAVASCULAIRE DISSEMINEE
Publication
Application
Priority
- DE 19753383 A 19971202
- EP 9807833 W 19981202
Abstract (en)
[origin: WO9927962A1] The present invention relates to the use of fibrinogen receptor-antagonists for preventing disseminated intravascular coagulation (DIC) related to sepsis or systemic inflammatory response syndrome (SIRS) in humans.
IPC 1-7
IPC 8 full level
A61K 31/216 (2006.01); A61K 31/4015 (2006.01); A61K 31/4365 (2006.01); A61K 31/445 (2006.01); A61K 31/4465 (2006.01); A61K 38/00 (2006.01); A61K 38/08 (2006.01); A61K 38/39 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61P 1/18 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 17/02 (2006.01); A61P 29/00 (2006.01); A61P 31/04 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61K 31/216 (2013.01); A61K 31/4015 (2013.01); A61K 31/4365 (2013.01); A61K 31/445 (2013.01); A61K 31/4465 (2013.01); A61K 38/39 (2013.01); A61P 1/18 (2017.12); A61P 7/02 (2017.12); A61P 9/10 (2017.12); A61P 17/02 (2017.12); A61P 29/00 (2017.12); A61P 31/04 (2017.12); C07K 16/2848 (2013.01)
Citation (search report)
See references of WO 9927962A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9927962 A1 19990610; CA 2312824 A1 19990610; DE 19753383 A1 19990610; EP 1035868 A1 20000920; JP 2001524534 A 20011204
DOCDB simple family (application)
EP 9807833 W 19981202; CA 2312824 A 19981202; DE 19753383 A 19971202; EP 98965225 A 19981202; JP 2000522947 A 19981202